Latest & greatest articles for divalproex

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on divalproex or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on divalproex and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for divalproex

1. Divalproex

Divalproex Top results for divalproex - Trip Database or use your Google+ account Find evidence fast ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4 (...) ) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for divalproex The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you

2018 Trip Latest and Greatest

2. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. (PubMed)

Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Bipolar disorder is a recurrent illness that is amongst the top 30 causes of disability worldwide and is associated with significant healthcare costs. In the past, emphasis was placed solely on the treatment of acute episodes of bipolar disorder; recently, the importance of episode prevention and of minimisation of iatrogenicity has been recognised. For many years, lithium was the only mood stabiliser

Full Text available with Trip Pro

2013 Cochrane

3. Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy (PubMed)

Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy The purpose of the present study was to evaluate the efficacy of divalproex for reducing aggressive behavior among children 6 to 13 years old with attention deficit hyperactivity disorder (ADHD) and a disruptive disorder whose chronic aggression was underresponsive to a prospective psychostimulant trial.Children received open stimulant treatment during a lead-in phase that averaged 5 (...) weeks. Agent and dose were assessed weekly and modified to optimize response. Children whose aggressive behavior persisted at the conclusion of the lead-in phase were randomly assigned to receive double-blind, flexibly dosed divalproex or a placebo adjunctive to stimulant for 8 weeks. Families received weekly behavioral therapy throughout the trial. The primary outcome measure was the proportion of children whose aggressive behavior remitted, defined by post-trial ratings of negligible or absent

Full Text available with Trip Pro

2010 EvidenceUpdates Controlled trial quality: uncertain

4. Divalproex and lithium are similarly cost effective for adults with bipolar disorder

Divalproex and lithium are similarly cost effective for adults with bipolar disorder Divalproex and lithium are similarly cost effective for adults with bipolar disorder | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Divalproex and lithium are similarly cost effective for adults with bipolar disorder Article Text Therapeutics Divalproex and lithium are similarly cost effective for adults with bipolar disorder Statistics from

2007 Evidence-Based Mental Health

5. Bipolar disorder in young people: divalproex sodium no more effective than lithium for maintenance

Bipolar disorder in young people: divalproex sodium no more effective than lithium for maintenance Bipolar disorder in young people: divalproex sodium no more effective than lithium for maintenance | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Bipolar disorder in young people: divalproex sodium no more effective than lithium for maintenance Article Text Therapeutics Bipolar disorder in young people: divalproex sodium no more

Full Text available with Trip Pro

2006 Evidence-Based Mental Health

6. Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD

Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD Article Text

Full Text available with Trip Pro

2006 Evidence-Based Mental Health

7. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial

Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2005 NHS Economic Evaluation Database.

8. Suicide risk in bipolar disorder during treatment with lithium and divalproex. (PubMed)

Suicide risk in bipolar disorder during treatment with lithium and divalproex. Several studies have suggested that lithium treatment reduces risk of suicide in bipolar disorder, but no research has examined suicide risk during treatment with divalproex, the most commonly prescribed mood-stabilizing drug in the United States.To compare risk of suicide attempt and suicide death during treatment with lithium with that during treatment with divalproex.Retrospective cohort study conducted at 2 large (...) integrated health plans in California and Washington.Population-based sample of 20 638 health plan members aged 14 years or older who had at least 1 outpatient diagnosis of bipolar disorder and at least 1 filled prescription for lithium, divalproex, or carbamazepine between January 1, 1994, and December 31, 2001. Follow-up for each individual began with first qualifying prescription and ended with death, disenrollment from the health plan, or end of the study period.Suicide attempt, recorded

Full Text available with Trip Pro

2003 JAMA

9. Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes

Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes Revicki D A, Paramore L C, Sommerville K W, Swann A C (...) , Zajecka J M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of divalproex sodium and olanzapine to treat acute mania associated with bipolar disorder. Treatment with divalproex was initiated at 20 mg/kg per day, while

2003 NHS Economic Evaluation Database.

10. Substitution of immediate-release valproic acid for divalproex sodium for adult psychiatric inpatients

Substitution of immediate-release valproic acid for divalproex sodium for adult psychiatric inpatients Substitution of immediate-release valproic acid for divalproex sodium for adult psychiatric inpatients Substitution of immediate-release valproic acid for divalproex sodium for adult psychiatric inpatients Sherr J D, Kelly D L Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Immediate-release valproic acid and divalproex sodium for adult psychiatric inpatients. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population Adult psychiatric inpatients. Setting The practice setting was a hospital chronic care ward. The economic analysis appears to have been carried out

1998 NHS Economic Evaluation Database.

11. Clinical and economic impact of replacing divalproex sodium with valproic acid

Clinical and economic impact of replacing divalproex sodium with valproic acid Clinical and economic impact of replacing divalproex sodium with valproic acid Clinical and economic impact of replacing divalproex sodium with valproic acid Cranor C W, Sawyer W T, Carson S W, Early J J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed (...) by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Divalproex sodium and valproic acid in the treatment of mentally retarded adults with epilepsy. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population Adults with a learning disability and epilepsy. Setting State-supported mental health facility setting. This study was carried out in the USA. Dates to which data relate The effectiveness data related

1997 NHS Economic Evaluation Database.

12. A pharmacoeconomic model of divalproex vs lithium in the acute and prophylactic treatment of bipolar I disorder

A pharmacoeconomic model of divalproex vs lithium in the acute and prophylactic treatment of bipolar I disorder A pharmacoeconomic model of divalproex vs lithium in the acute and prophylactic treatment of bipolar I disorder A pharmacoeconomic model of divalproex vs lithium in the acute and prophylactic treatment of bipolar I disorder Keck P E, Nabulsi A A, Taylor J L, Henke C J, Chmiel J J, Stanton S P, Bennett J A Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Lithium vs divalproex for patients with acute mania in bipolar I disorders. Type of intervention Treatment and secondary prevention. Economic study type Cost effectiveness analysis. Study population Male and female patients with bipolar I disorders who had been

1996 NHS Economic Evaluation Database.

13. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. (PubMed)

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. To compare the effectiveness of divalproex sodium with that of lithium and placebo in patients with acute mania.Randomized, double-blind, parallel-group study of treatment outcomes in patients with manic-depressive illness.A total of 179 hospitalized, acutely manic patients meeting the Research Diagnostic Criteria for manic disorder, approximately half of whom had been nonresponsive (...) to lithium previously, were studied at nine university-affiliated hospitals.After a minimum 3-day washout period, random assignment for 21 days to divalproex, lithium, or placebo in a 2:1:2 ratio. Dosage of divalproex and lithium was increased if tolerated to a target concentration of 1041 mumol/L (150 micrograms/mL) or 1.5 mmol/L (conventionally expressed as milliequivalents per liter), respectively.Primary outcome measures were changes in the Mania Rating scale derived from the Schedule for Affective

1994 JAMA Controlled trial quality: predicted high